Early Pregnancy Safety Concerns With ACE Inhibitors Could Affect ARBs

Concerns about exposure to angiotensin-converting enzyme inhibitors during the first trimester of pregnancy could have consequences for other classes of antihypertensives, including angiotensin II receptor blockers